Agilon Health Inc.

NYSE: AGL · Real-Time Price · USD
1.11
0.05 (4.72%)
At close: Aug 15, 2025, 3:59 PM
1.10
-1.35%
After-hours: Aug 15, 2025, 07:53 PM EDT

Agilon Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5.9B 5.99B 6.06B 5.59B 5.36B 5.03B 4.56B 4.19B 3.67B 3.19B 2.71B 2.48B 2.25B 2.07B 1.83B 1.69B 1.55B 1.34B
Cost of Revenue
6.01B 6.02B 6.07B 5.66B 5.33B 4.97B 4.49B 5.25B 4.74B 4.28B 3.83B 2.38B 2.15B 1.99B 1.77B 1.62B 1.46B 1.24B
Gross Profit
-110.62M -31.93M -13.4M -68.26M 26.39M 57.31M 65.36M -1.06B -1.07B -1.09B -1.12B 103.18M 92.22M 81.09M 67.71M 72.11M 82.58M 98.27M
Operating Income
-379.75M -306.19M -288.85M -345.05M -260.51M -247.85M -227.17M -126.15M -106.7M -97.93M -112.33M -106.8M -112.88M -390.19M -403.83M -385.82M -360.06M -62.95M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-327.69M -253.63M -248.83M -311.02M -224.28M -209.75M -198.67M -87.74M -87.41M -92.14M -105.69M -106.99M -113.79M -390.22M -404.6M -386.16M -361.69M -68.2M
Net Income
-315.66M -241.97M -251.39M -328.48M -242.3M -228.37M -215.05M -88.21M -87.44M -91.73M -107.03M -108.05M -113.22M -391.03M -406.83M -373.98M -349.96M -59.03M
Selling & General & Admin
245.12M 257.58M 265.63M 270.57M 281.58M 294.34M 286.99M 297.5M 275.34M 245.77M 218.94M 197.58M 192.24M 457.88M 455.82M 443.34M 428.62M 147.46M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
30.5M 23.18M 16.31M 6.22M 5.69M 21.38M 25.57M 25.57M 24.76M 12.12M 11.3M 11.3M 6.15M 6.07M 6.13M 9.01M 8.81M 5.77M
Operating Expenses
275.62M 280.76M 281.94M 276.79M 286.89M 305.17M 302M 312.52M 288.5M 256.45M 228.81M 207.44M 202.57M 468.75M 466.74M 457.93M 442.64M 161.22M
Interest Expense
6.28M 6.41M 6.18M 6.6M 6.59M 6.45M 6.66M 6.37M 5.76M 5.15M 4.53M 3.66M 3.52M 4.08M 6.15M 7.26M 8.35M 8.93M
Selling & Marketing Expenses
n/a -868K -3.28M -1.86M -1.86M -996K 1.42M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.28B 6.3B 6.35B 5.94B 5.62B 5.27B 4.79B 5.56B 5.02B 4.54B 4.06B 2.59B 2.36B 2.46B 2.23B 2.08B 1.91B 1.4B
Income Tax Expense
1.43M 1.78M 1.45M -39K 1.76M 2.42M 791K 631K -20K -513K 1.18M 889K 586K 441K 528K 1.5M 1.28M 881K
Shares Outstanding (Basic)
413.84M 412.94M 412.04M 411.59M 411.27M 408.94M 406.48M 405.79M 410.34M 413.14M 412.1M 411.06M 407.34M 424.06M 372.93M 391.23M 377.44M 325.66M
Shares Outstanding (Diluted)
413.84M 412.94M 412.04M 411.59M 411.27M 408.94M 406.48M 405.79M 410.34M 426.59M 412.1M 411.06M 407.34M 424.06M 372.93M 391.23M 377.44M 325.66M
EPS (Basic)
-0.77 -0.59 -0.62 -0.81 -0.6 -0.56 -0.53 -0.22 -0.22 -0.23 -0.26 -0.27 -0.29 -1.03 -1.08 -0.99 -0.93 -0.16
EPS (Diluted)
-0.77 -0.59 -0.62 -0.81 -0.6 -0.56 -0.53 -0.22 -0.22 -0.23 -0.26 -0.27 -0.29 -1.03 -1.08 -0.99 -0.93 -0.16
EBITDA
-297.75M -224.98M -230.59M -294.13M -205.02M -190.99M -187.28M -77.46M -79.64M -87.5M -87.39M -89.83M -96.27M -371.58M -383.78M -364.12M -339M -45.06M
EBIT
-324.66M -250.47M -245.89M -303.57M -213.55M -199.14M -193.85M -87.3M -87.63M -93M -101.16M -103.34M -110.26M -386.15M -398.45M -378.9M -353.35M -59.27M
Depreciation & Amortization
26.91M 25.5M 24.46M 22.7M 21.8M 21.4M 19.75M 18.92M 17.06M 14.59M 13.77M 13.5M 13.99M 14.56M 14.67M 14.79M 14.35M 14.22M